Linagliptin in Phase III Trial Confirm Favourable Efficacy and Safety - Diabetes In Control |
|
|
Diabetes In ControlIts primarily non-renal route of excretion may be an advantage in patients with renal impairment, he suggested, noting that up to half of people with ...
|